Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trial

Published:2021-08 Issue: Volume:97 Page:107715
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Abbasirad Faezeh,Shaygannejad Vahid,Hosseininasab Fahimeh,Mirmosayyeb Omid,Mahaki Behzad,Moayedi Behjat,Esmaeil Nafiseh

Funder

Isfahan University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference32 articles.

1. Multiple sclerosis–the plaque and its pathogenesis;Frohman;N Engl J Med,2006

2. Reply: To PMID 11456302;Polman;Ann Neurol,2006

3. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand;Bielekova;Nat Med,2000

4. Effector T Cells in Multiple Sclerosis;Kaskow;Cold Spring Harb Perspect Med,2018

5. Oxidative stress in multiple sclerosis: Central and peripheral mode of action;Ohl;Exp Neurol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose–response meta‐analysis;Phytotherapy Research;2024-03-12

2. Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight;Frontiers in Neuroscience;2023-05-18

3. An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database;British Journal of Clinical Pharmacology;2022-11-10

4. Mechanistic Insights into the Pharmacological Significance of Silymarin;Molecules;2022-08-21

5. Evaluation of the efficacy of oral nano‐silymarin formulation in hospitalized patients with COVID‐19: A double‐blind placebo‐controlled clinical trial;Phytotherapy Research;2022-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3